Health guide
How to Tell If a Compounding Pharmacy Is Legit: A 7-Point Checklist
Quick Answer: You can do a meaningful amount of vetting yourself before trusting any compounding pharmacy: confirm its state license, look for PCAB accreditation, ask for a batch-specific Certificate of Analysis (COA), and find out where the active ingredient comes from. Important context first: compounded semaglutide is not FDA-approved and is not an equivalent or interchangeable version of Ozempic or Wegovy. A state license or PCAB accreditation tells you about the facility’s oversight; neither means the medication itself is FDA-approved. Verifying a pharmacy reduces risk, but it does not eliminate it. This article is educational and is not medical advice.
Quick Facts: Vetting a Compounding Pharmacy
- 🔍 You can verify a lot yourself: State board of pharmacy lookups are public and free to search, and NABP provides additional online pharmacy verification resources.
- 📋 503A compounding: Patient-specific compounding by a state-licensed pharmacy pursuant to an individual prescription — not a statement that any compounded drug is FDA-approved.
- 🏅 PCAB accreditation: A voluntary, third-party quality credential. Useful signal; not FDA approval.
- 🧪 Certificate of Analysis (COA): Documents that a specific batch was tested for potency, purity, and sterility.
- 🌍 API sourcing: Where the active pharmaceutical ingredient comes from matters; “research use only” material is a red flag.
- ⚖️ Not FDA-approved: Compounded semaglutide has not been reviewed by the FDA and has no FDA-reviewed labeling of its own.
- 🩺 A clinical decision: Whether a compounded option is appropriate for you is decided with a licensed prescriber, not by a checklist alone.
Why This Matters More Now
Compounded GLP-1 medications, including semaglutide, are under active FDA attention. The agency has issued public communications about the risks of products sold outside the legal compounding framework, and it has taken action against unlawfully marketed or poor-quality products. For a period, semaglutide appeared on the FDA’s drug shortage list; the FDA declared that shortage resolved in February 2025 and removed semaglutide from the list. As a result, a shortage rationale is no longer a basis for compounding semaglutide. Today, compounding generally turns on a patient-specific clinical need that an FDA-approved product cannot meet, as determined by a licensed prescriber.
What does that mean for you as a consumer? The market still includes a wide range of sellers, from licensed U.S. pharmacies with documented testing to overseas sites and “research chemical” vendors operating entirely outside the law. The label “compounded semaglutide” can sit on top of very different realities. Learning to tell them apart is worth your time.
One point up front, because it is the most common misunderstanding: compounded semaglutide is not FDA-approved, and it is not interchangeable with Ozempic or Wegovy. A state license or PCAB accreditation confirms that a facility is subject to certain oversight; neither is FDA approval of the medication itself. For more on that distinction, see our guide to whether compounded semaglutide is FDA-approved. Vetting a pharmacy reduces certain risks. It does not eliminate them.
1. State Licensure: How to Verify It Yourself
Every legitimate pharmacy in the United States holds a license from a state board of pharmacy. This is the most basic credential, and it is one you can check yourself in a few minutes, for free.
How to Look It Up
- Get the pharmacy’s legal name and state. Ask your telehealth provider which pharmacy dispenses or compounds your medication, and in which state it is located. A provider that will not tell you is itself a warning sign.
- Find that state’s board of pharmacy. Search for “[state] board of pharmacy license lookup.” Most state boards publish a searchable online license verification tool.
- Search by pharmacy name or license number. Confirm the license is active and in good standing, and that the name and address match what your provider told you.
- Check non-resident licensing. A pharmacy that ships to you across state lines generally also needs a non-resident license in your state. You can often verify this with your own state’s board.
- Use the NABP as a backstop. The National Association of Boards of Pharmacy (NABP) runs verification resources, including its .pharmacy Verified and Safe Pharmacy programs, that can help you confirm whether an online pharmacy is legitimate.
A current, in-good-standing license confirms the pharmacy is a real, regulated entity subject to its state board. That is necessary, but it is not the whole picture: licensure does not, by itself, tell you how a specific compounded preparation was tested, where the active ingredient came from, or whether the FDA has reviewed the medication (it has not).
2. 503A Compounding Pharmacies: What Oversight Applies
Under the Federal Food, Drug, and Cosmetic Act, a 503A pharmacy (traditional compounding pharmacy) compounds medications pursuant to a valid, patient-specific prescription for an individual patient. The primary regulator is the state board of pharmacy. 503A pharmacies are subject to USP compounding standards — including USP <797> for sterile preparations and USP <800> for hazardous drugs — and to state board inspections.
| Factor | 503A (Traditional Compounding) |
|---|---|
| Primary regulator | State board of pharmacy |
| Prescription required | Yes — for a specific, individual patient |
| Manufacturing standard | USP compounding standards (USP <797>, USP <800>) |
| Verification path | State board of pharmacy license lookup |
The state board lookup from Step 1 is your primary verification path for a 503A pharmacy. Legitimate 503A pharmacies hold active state licenses you can confirm publicly, and many pursue voluntary PCAB accreditation as an additional quality signal.
Here is the point that matters most: state board licensure and USP compliance tell you about the type of oversight the pharmacy is subject to — not that any compounded preparation is FDA-approved. Compounded semaglutide dispensed from a licensed 503A pharmacy is not an FDA-approved drug and is not equivalent or interchangeable with Ozempic or Wegovy. Whether a compounded option is appropriate for you is a clinical decision you make with your prescriber.
3. PCAB Accreditation
PCAB (the Pharmacy Compounding Accreditation Board, part of ACHC) is a voluntary, third-party accreditation program for compounding pharmacies. To earn it, a pharmacy submits to an external review of its compounding practices, facilities, documentation, and quality systems against established standards, and to periodic reaccreditation.
Why it is a useful signal: accreditation is voluntary and adds an independent layer of scrutiny beyond the minimum a pharmacy needs to hold its license. A pharmacy that has chosen to pursue and maintain PCAB accreditation has invited an outside body to inspect how it works. You can typically verify a pharmacy’s accreditation status by searching the accreditor’s directory or asking the pharmacy for its current certificate.
What it does not mean: PCAB accreditation is a quality credential for the facility and its processes. It is not FDA approval of any medication the pharmacy compounds, and it does not make compounded semaglutide equivalent to an FDA-approved product. Treat it as one positive data point among several, not as a guarantee.
4. Certificate of Analysis (COA) and Third-Party Batch Testing
A Certificate of Analysis (COA) is a document that reports laboratory testing results for a specific batch of a compounded medication. It is one of the most concrete things you can ask for, because it ties a piece of paper to the exact vial you receive.
What a COA Should Include
- 🧪 Potency: The measured amount of active ingredient, verified against the label claim.
- 🔬 Purity: Tested against defined specifications.
- 🦠 Sterility: For injectable preparations, confirmation of no bacterial or fungal growth.
- 💉 Endotoxin: Bacterial endotoxin testing below defined limits, which matters for injection safety.
- 🔢 Batch / lot number: It should match the number printed on your vial.
- 🏢 Testing lab: Ideally an independent, third-party laboratory, named on the document.
Third-party testing, meaning testing by a laboratory independent of the pharmacy, adds credibility because the pharmacy is not the only party vouching for its own product. When you receive your medication, match the batch number on the COA to the number on the vial. If a provider cannot produce a batch-specific COA, that is a meaningful gap.
A COA documents that a batch was tested and met specifications. It is valuable. It is also not a substitute for FDA approval, and it does not, on its own, make a compounded medication safe or effective for you. It is evidence about manufacturing quality, not a clinical clearance.
5. Where the API Is Sourced
The active pharmaceutical ingredient (API) is the semaglutide itself. Where it comes from is a quiet but important part of vetting a pharmacy, because the legal compounding framework expects the API to meet specific requirements.
What to Ask and Look For
- ✅ API that meets applicable regulatory requirements: Sourced from suppliers and facilities subject to applicable regulatory requirements for human pharmaceutical use, not material sold “for research use only.”
- ✅ FDA-registered API facilities: Legitimate U.S. compounders source their API from registered facilities and maintain documentation of that sourcing.
- ✅ Documentation on request: A reputable pharmacy can speak to where its API comes from and that it is intended for human pharmaceutical use.
- ❌ “Research use only,” “not for human use,” or overseas gray-market sourcing: These indicate material outside the legal pharmaceutical supply chain.
For a deeper look at the supply chain behind compounded semaglutide, see our article on how semaglutide works and is sourced. The short version: API origin separates a regulated medication from a gray-market product, even when the molecule on the label is the same. Whether a particular source is permissible for your situation is a determination for the prescriber and pharmacy, not something a patient confirms alone.
6. Red Flags (In Our Judgment)
The signals below are, in our opinion, reasons to slow down and ask more questions. They are judgment calls, not a scientific safety test, and the absence of these flags does not guarantee a product is safe, effective, or appropriate for you. Use them as prompts for caution, not as a green light.
| What you see | Why we’d treat it as a warning sign |
|---|---|
| A price that seems too good to be true | In our judgment, a price far below what a licensed pharmacy could plausibly charge can signal gray-market or “research-only” sourcing. Price alone does not confirm quality or legality, but a suspiciously low number warrants questions about the source. |
| No way to reach a pharmacist | Legitimate pharmacies provide pharmacist access for questions. No phone, no named pharmacy, no one to ask, in our view, is a reason for concern. |
| No Certificate of Analysis available | If a seller cannot produce batch-specific testing documentation, you have no evidence about potency, purity, or sterility. |
| ”Research use only” or “not for human use” labeling | This material is, by its own labeling, not intended for human use and is unlawful to sell for human consumption. |
| Gray-market or overseas sourcing | Products shipped from overseas or unknown sellers operate outside FDA oversight and the legal compounding framework; identity, quality, and sterility cannot be verified. |
| No prescription required | Semaglutide is a prescription medication. Selling it without a prescription is unlawful and removes clinical oversight. |
| Claims of being “FDA-approved” or “the same as Ozempic” | Compounded semaglutide is not FDA-approved and is not interchangeable with the brand. A seller that claims otherwise is, in our view, either uninformed or misleading you. |
If a source raises these concerns, you can report it to the FDA through its MedWatch program or to the relevant state board of pharmacy.
7. Questions to Ask Before You Buy
If you and your clinician are considering a compounded option, these are reasonable questions to put to any provider or pharmacy. A legitimate operation should answer them readily.
- Which pharmacy will dispense or compound my medication, and in what state? You need a name and location to verify anything.
- Is the pharmacy a licensed 503A compounding pharmacy? Your medication should be compounded patient-specifically, pursuant to a valid prescription issued for you individually.
- Is the pharmacy licensed in good standing, including in my state? You can confirm this independently on the state board lookup.
- Is the pharmacy PCAB-accredited? If so, can you share the current certificate?
- Will I receive a batch-specific Certificate of Analysis, and is testing third-party?
- Where does the active ingredient come from, and is it pharmaceutical-grade (not “research use only”)?
- Who is the prescribing clinician, and what medical review happens before prescribing?
Notice what is not on this list: questions about how to dose the medication yourself. Dosing and titration are decisions for your prescriber, made with knowledge of your medical history; they are not something to figure out from a vendor or a blog. For pricing, ask the provider directly or see the product page rather than relying on a quoted “deal.”
The 7-Point Verification Checklist
A printable summary you can work through before trusting any compounding pharmacy. Completing every item reduces risk; it does not eliminate risk, and it does not make compounded semaglutide FDA-approved.
| # | Check | How to verify |
|---|---|---|
| 1 | State license active and in good standing | State board of pharmacy license lookup (free, public) |
| 2 | Licensed 503A compounding pharmacy confirmed | Ask the provider; verify state license on state board lookup; confirm compounding is patient-specific per your prescription |
| 3 | PCAB accreditation (if applicable) | Accreditor directory or current certificate from the pharmacy |
| 4 | Batch-specific COA available | Request it; match the batch number to your vial; prefer third-party testing |
| 5 | API meets applicable regulatory requirements and is documented | Ask about sourcing; reject “research use only” material |
| 6 | No red flags present | Pharmacist access, prescription required, no “FDA-approved”/equivalence claims, no suspicious pricing |
| 7 | Licensed prescriber oversight | Confirm a clinician reviews your history and issues a prescription |
How Contour Health Vets Its Partner Pharmacies
Contour Health works with WellSync and other state-licensed 503A compounding pharmacies in the WellSync network. Medications are compounded patient-specifically pursuant to a valid prescription, prescribing is overseen by licensed clinicians, and batch testing documentation is part of the process.
- ✅ State-licensed 503A compounding pharmacies: WellSync and other state-licensed 503A pharmacies in the WellSync network, compounding patient-specifically pursuant to valid prescriptions.
- ✅ Prescriber oversight: A licensed clinician reviews your medical history before any prescription is issued.
- ✅ Batch testing documentation: Certificate of Analysis information is available for the medication you receive.
- ✅ Transparent sourcing: We can speak to which pharmacies are used and how the medication is handled.
We want to be clear about what this does and does not mean. Sourcing from licensed pharmacies with prescriber oversight and batch testing reduces certain risks compared with unverified sellers. It does not eliminate risk, and it does not make compounded semaglutide FDA-approved or interchangeable with Ozempic or Wegovy. Whether a compounded option is appropriate for you is a clinical decision you make with a licensed clinician.
See Contour Health’s sourcing and pricing →
FAQ
How do I know if a compounding pharmacy is legitimate?
Start with its state license: search your state board of pharmacy’s license lookup and confirm the pharmacy is active and in good standing, including a non-resident license in your state if it ships to you. Then look for PCAB accreditation, ask for a batch-specific Certificate of Analysis, and confirm there is licensed prescriber oversight. Each step adds confidence. None of them makes compounded semaglutide FDA-approved, and vetting reduces but does not eliminate risk.
What is a Certificate of Analysis (COA) and should I ask for one?
A COA is a document reporting laboratory test results for a specific batch, typically covering potency, purity, sterility, and endotoxin, along with the batch number and the testing lab. Yes, you should ask for one, and you should match the batch number on the COA to the number on your vial. Third-party (independent lab) testing is a stronger signal than in-house testing alone. A COA documents manufacturing quality for that batch; it is not the same as FDA approval and does not by itself confirm the medication is right for you.
What are red flags of a fake or shady compounded semaglutide supplier?
In our judgment, warning signs include a price that seems too good to be true, no way to reach a pharmacist, no batch-specific COA, products labeled “research use only” or “not for human use,” overseas or gray-market sourcing, no prescription required, and claims that the product is “FDA-approved” or “the same as Ozempic” (it is neither). These are judgment calls meant to prompt caution and questions, not a safety guarantee; their absence does not prove a product is safe.
Is PCAB accreditation important?
It is a useful, positive signal. PCAB accreditation means a pharmacy voluntarily submitted its compounding practices and quality systems to independent, third-party review. It adds a layer of scrutiny beyond the minimum required to hold a license. That said, it is a credential for the facility and its processes, not FDA approval of any medication, so treat it as one data point among several rather than a guarantee.
How can I avoid counterfeit semaglutide?
Buy only through a licensed pathway: a licensed clinician who issues a prescription and a licensed U.S. pharmacy that can document its sourcing and batch testing. Verify the pharmacy’s state license yourself, ask for a batch-specific COA and match it to your vial, and avoid any seller that ships from overseas, skips the prescription, labels material “research use only,” or claims to be FDA-approved. These steps lower your risk of receiving a counterfeit or substandard product, but no consumer step can fully guarantee a compounded medication’s quality, and compounded semaglutide remains not FDA-approved.
Considering a Compounded Option?
If you and a licensed clinician decide a compounded option is appropriate for you, Contour Health works with vetted, licensed U.S. pharmacies through WellSync, includes prescriber oversight, and makes batch testing documentation available. Compounded semaglutide is not FDA-approved; whether it is right for you is a clinical decision.
See Contour Health’s sourcing and pricing →
✓ Licensed U.S. pharmacies | ✓ COA available | ✓ Licensed prescriber oversight
Related Articles
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider with any questions about a medical condition. Compounded medications are not FDA-approved; the FDA does not verify the safety or effectiveness of compounded drugs. Results vary by individual.
Ready to start your journey?
Take our quick assessment to see if doctor-supervised GLP-1 treatment is right for you.
Get Started
